Inventor
CONTE UBALDO
IT25 patents
⚠️ This page may combine multiple inventors who share the name “CONTE UBALDO”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
JAGOTEC AG
13 patentsUS6294200B1Sep 25, 2001
Pharmaceutical tablet suitable to deliver the active substance in subsequent and predeterminable times
JAGOTEC AG159 citations99
US5780057AJul 14, 1998
Pharmaceutical tablet characterized by a showing high volume increase when coming into contact with biological fluids
JAGOTEC AG233 citations99
US5422123AJun 6, 1995
Tablets with controlled-rate release of active substances
JAGOTEC AG313 citations99
US4839177AJun 13, 1989
System for the controlled-rate release of active substances
JAGOTEC AG311 citations99
US6027748AFeb 22, 2000
Pharmaceutical tablet, completely coated, for controlled release of active principles that present problems of bio-availability linked to gastro-intestinal absorption
JAGOTEC AG194 citations98
US5738874AApr 14, 1998
Pharmaceutical tablet capable of liberating one or more drugs at different release rates
JAGOTEC AG276 citations98
US5650169AJul 22, 1997
Pharmaceutical tablet capable of releasing the active ingredients contained therein at subsequent times
JAGOTEC AG116 citations97
US5464633ANov 7, 1995
Pharmaceutical tablets releasing the active substance after a definite period of time
JAGOTEC AG151 citations97
US6183778B1Feb 6, 2001
Pharmaceutical tablet capable of liberating one or more drugs at different release rates
JAGOTEC AG189 citations96
US6221395B1Apr 24, 2001
Controlled release pharmaceutical tablets containing an active principle of low water solubility
JAGOTEC AG76 citations95
US5476654ADec 19, 1995
Process for preparing pharmaceutical compositions having an increased active substance dissolution rate, and the compositions obtained
JAGOTEC AG37 citations91
US7927624B2Apr 19, 2011
Hydrophilic/lipophilic polymeric matrix dosage formulation
JAGOTEC AG5 citations74
US5849329ADec 15, 1998
Process for preparing pharmaceutical composition having an increased active substance dissolution rate, and the compositions obtained
JAGOTEC AG7 citations72
LISAPHARMA SPA
3 patentsUS4605741AAug 12, 1986
Pharmaceutically active salt derivative of 3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde phosphate
LISAPHARMA SPA47 citations91
US5246697ASep 21, 1993
Use of sucralfate humid gel as vehicle for drugs having topic activity and for cosmetics
LISAPHARMA SPA14 citations71
US5321013AJun 14, 1994
Pharmaceutical compositions in the form of stable sucralfate suspensions free of suspending agents
LISAPHARMA SPA12 citations68
EKITA INVESTMENTS NV
2 patentsUS5626874AMay 6, 1997
Controlled release pharmaceutical tablet having lenticular form
EKITA INVESTMENTS NV104 citations96
US5487901AJan 30, 1996
Process for preparing pharmaceutical tablet capable of releasing the active ingredients contained therein at subsequent times
EKITA INVESTMENTS NV90 citations94